{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:24:04Z","timestamp":1772763844488,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["BMH4-CT98\u20133087"],"award-info":[{"award-number":["BMH4-CT98\u20133087"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["QLRT-1999\u201300037"],"award-info":[{"award-number":["QLRT-1999\u201300037"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["QLRT-2000\u201300657"],"award-info":[{"award-number":["QLRT-2000\u201300657"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009471","name":"EkstraStiftelsen Helse og Rehabilitering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.it.2006.02.006","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T08:48:25Z","timestamp":1142326105000},"page":"188-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A gut feeling for joint inflammation \u2013 using coeliac disease to understand rheumatoid arthritis"],"prefix":"10.1016","volume":"27","author":[{"given":"\u00d8yvind","family":"Molberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludvig M.","family":"Sollid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2006.02.006_bib1","doi-asserted-by":"crossref","unstructured":"Green, P.H. and Jabri, B. (2006) Celiac Disease. Annual Review of Medicine 57, 14.1\u201314.15","DOI":"10.1146\/annurev.med.57.051804.122404"},{"key":"10.1016\/j.it.2006.02.006_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nri885","article-title":"Coeliac disease: dissecting a complex inflammatory disorder","volume":"2","author":"Sollid","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2006.02.006_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.191.4.603","article-title":"The intestinal T cell response to \u03b1-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase","volume":"191","author":"Arentz-Hansen","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2006.02.006_bib5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1053\/gast.2002.33606","article-title":"The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides","volume":"122","author":"Vader","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.it.2006.02.006_bib6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/gast.2002.35381","article-title":"Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues","volume":"123","author":"Arentz-Hansen","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.it.2006.02.006_bib7","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.1074129","article-title":"Structural basis for gluten intolerance in celiac sprue","volume":"297","author":"Shan","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.it.2006.02.006_bib8","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1021\/pr050173t","article-title":"Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue","volume":"4","author":"Shan","year":"2005","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.it.2006.02.006_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4049\/jimmunol.175.1.254","article-title":"Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation","volume":"175","author":"Qiao","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1124\/jpet.104.073312","article-title":"Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization","volume":"312","author":"Marti","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.it.2006.02.006_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jbspin.2003.10.003","article-title":"Is the celiac disease model relevant to rheumatoid arthritis?","volume":"71","author":"Meyer","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.it.2006.02.006_bib12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2006.02.006_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1742-4658.2004.04476.x","article-title":"Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance","volume":"272","author":"Esposito","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.it.2006.02.006_bib14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","article-title":"PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease","volume":"25","author":"Vossenaar","year":"2003","journal-title":"BioEssays"},{"key":"10.1016\/j.it.2006.02.006_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1542-3565(05)00532-X","article-title":"Celiac disease genetics: current concepts and practical applications","volume":"3","author":"Sollid","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.it.2006.02.006_bib16","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1073\/pnas.0306885101","article-title":"Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease","volume":"101","author":"Kim","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2006.02.006_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.it.2006.02.006_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2006.02.006_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1074-7613(00)80369-6","article-title":"X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II","volume":"7","author":"Dessen","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.it.2006.02.006_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/368215a0","article-title":"Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide","volume":"368","author":"Stern","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.it.2006.02.006_bib21","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/art.10989","article-title":"Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families","volume":"48","author":"Jawaheer","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2006.02.006_bib22","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1172\/JCI117624","article-title":"CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response","volume":"94","author":"Li","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2006.02.006_bib23","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.4049\/jimmunol.169.11.6625","article-title":"Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages","volume":"169","author":"Tsark","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib24","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","article-title":"Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin","volume":"7","author":"Raza","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.it.2006.02.006_bib25","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/gut.52.11.1562","article-title":"Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity","volume":"52","author":"Dieterich","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.it.2006.02.006_bib26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2006.02.006_bib28","first-page":"1696","article-title":"Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis","volume":"30","author":"Raats","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.it.2006.02.006_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","article-title":"Use and significance of anti-CCP autoantibodies in rheumatoid arthritis","volume":"45","author":"Zendman","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.it.2006.02.006_bib30","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2006.02.006_bib31","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","article-title":"A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis","volume":"6","author":"Berglin","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.it.2006.02.006_bib32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2006.02.006_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/ard.2003.015990","article-title":"Unlocking the \u2018PAD\u2019 lock on rheumatoid arthritis","volume":"63","author":"Utz","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.it.2006.02.006_bib34","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.4049\/jimmunol.175.9.5575","article-title":"The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis","volume":"175","author":"van Gaalen","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky's postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol. Today"},{"issue":"Suppl. 2","key":"10.1016\/j.it.2006.02.006_bib36","doi-asserted-by":"crossref","first-page":"ii46","DOI":"10.1136\/ard.2004.028241","article-title":"Should infection still be considered as the most likely triggering factor for rheumatoid arthritis?","volume":"63","author":"Carty","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.it.2006.02.006_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.it.2006.02.006_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"Hue","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.it.2006.02.006_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.coi.2005.09.015","article-title":"Is celiac disease an autoimmune disorder?","volume":"17","author":"Sollid","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib40","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1073\/pnas.1632807100","article-title":"Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis","volume":"100","author":"Groh","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2006.02.006_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11926-003-0003-y","article-title":"Antigen-specific T cells in Rheumatoid Arthritis","volume":"5","author":"Bennett","year":"2003","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.it.2006.02.006_bib42","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/art.10472","article-title":"Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse","volume":"46","author":"Burkhardt","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2006.02.006_bib43","doi-asserted-by":"crossref","first-page":"R477","DOI":"10.1186\/ar1213","article-title":"Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis","volume":"6","author":"Cook","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.it.2006.02.006_bib44","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1073\/pnas.132254199","article-title":"Predominant selection of T cells specific for the glycosylated collagen type II epitope (263\u2013270) in humanized transgenic mice and in rheumatoid arthritis","volume":"99","author":"Backlund","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2006.02.006_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-200404000-00002","article-title":"Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401)","volume":"327","author":"Rosloniec","year":"2004","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.it.2006.02.006_bib46","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1073\/pnas.86.2.636","article-title":"Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis","volume":"86","author":"Londei","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2006.02.006_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1073\/pnas.97.1.291","article-title":"Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis","volume":"97","author":"Kotzin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2006.02.006_bib48","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/j.gastro.2005.07.054","article-title":"Unexpected role of surface transglutaminase type II in celiac disease","volume":"129","author":"Maiuri","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.it.2006.02.006_bib49","doi-asserted-by":"crossref","first-page":"34109","DOI":"10.1074\/jbc.M204521200","article-title":"Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process","volume":"277","author":"Fleckenstein","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2006.02.006_bib50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.20012028","article-title":"Specificity of tissue transglutaminase explains cereal toxicity in celiac disease","volume":"195","author":"Vader","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2006.02.006_bib51","doi-asserted-by":"crossref","unstructured":"Dieterich, W. et al. (2005) Crosslinking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut (in press)","DOI":"10.1136\/gut.2005.069385"},{"key":"10.1016\/j.it.2006.02.006_bib52","doi-asserted-by":"crossref","first-page":"17607","DOI":"10.1074\/jbc.M310198200","article-title":"Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides","volume":"279","author":"Fleckenstein","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2006.02.006_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/rheumatology\/keh414","article-title":"Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis","volume":"44","author":"Chang","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.it.2006.02.006_bib54","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/art.21220","article-title":"Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity","volume":"52","author":"De Rycke","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2006.02.006_bib55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","article-title":"Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages","volume":"63","author":"Vossenaar","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.it.2006.02.006_bib56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2004.11.152","article-title":"Comparison of enzymatic properties between hPADI2 and hPADI4","volume":"327","author":"Nakayama-Hamada","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.it.2006.02.006_bib57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","article-title":"Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis","volume":"34","author":"Suzuki","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2006.02.006_bib58","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/498651","article-title":"Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4","volume":"77","author":"Plenge","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.it.2006.02.006_bib59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/03009740410004990","article-title":"Peptidyl arginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sj\u00f8gren syndrome","volume":"32","author":"Nissinen","year":"2003","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.it.2006.02.006_bib60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/03009740510026346-1","article-title":"Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis","volume":"34","author":"Takizawa","year":"2005","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.it.2006.02.006_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0","article-title":"Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis","volume":"44","author":"Reparon-Schuijt","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2006.02.006_bib62","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","article-title":"The presence of citrullinated proteins is not specific for rheumatoid synovial tissue","volume":"50","author":"Vossenaar","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2006.02.006_bib63","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.4049\/jimmunol.174.8.5057","article-title":"Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides","volume":"174","author":"Chapuy-Regaud","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib64","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/eji.200526000","article-title":"Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis","volume":"35","author":"Burkhardt","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib65","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the \u03b1- and \u03b2-chains of fibrin","volume":"166","author":"Masson-Bessiere","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib66","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.it.2006.02.006_bib67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1196\/annals.1313.025","article-title":"A deiminated viral peptide to detect antibodies in rheumatoid arthritis","volume":"1050","author":"Merlini","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.it.2006.02.006_bib68","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated \u03b1-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.it.2006.02.006_bib69","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2006.02.006_bib70","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/art.1780340809","article-title":"Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis","volume":"34","author":"Weinberg","year":"1991","journal-title":"Arthritis Rheum."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490606000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490606000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:59:22Z","timestamp":1761461962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490606000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1471490606000548"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2006.02.006","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A gut feeling for joint inflammation \u2013 using coeliac disease to understand rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2006.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}